Furthermore, in addition to those genes previously associated with lung cancer, TSGs and oncogenes known to be deregulated in other cancer types–such as PRDM2 and SIAH2, respectively – were also altered at the genetic, epigenetic and gene expression levels. The gene discussed is PRDM2; the disease is lung carcinoma.